A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva
disease modifying therapies
multiple sclerosis
patient engagement
patient reported experience measures
patient reported outcomes
patient support program
treatment adherence
Journal
Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
06
2022
accepted:
15
07
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
epublish
Résumé
Evidence suggests that organizational models that provide care interventions including patient support programs may increase patient adherence to multiple sclerosis (MS) therapies by providing tailored symptom management, informational support, psychological and/or social support, lifestyle changes, emotional adjustment, health education, and tailored coaching, thus improving patients' overall quality of life across the disease course. The main objective of this study was to describe MS patients' self-reported experience of a nurse-led, telephone-based PSP and to explore its potential role in improving disease and therapy management skills. Survey data were analyzed from a subset of patients relapsing-remitting MS (RRMS) using interferon beta-1a already registered in the adveva In total, 244 patient data at baseline were analyzed, of which 115 had a follow-up of at least 6 months. Results from this study provide an early view into the role of this PSP in improving the patients reported overall experience regarding disease management and injectable therapy, thus potentially ameliorating treatment adherence and decreasing health care cost. Moreover, study findings confirm the role of providing a patient-focused support by addressing non-medication-related topics in the PSP consultations. Indeed, patients involved in the adveva As such, it is reasonable to conclude that the involvement in the adveva
Sections du résumé
Background
UNASSIGNED
Evidence suggests that organizational models that provide care interventions including patient support programs may increase patient adherence to multiple sclerosis (MS) therapies by providing tailored symptom management, informational support, psychological and/or social support, lifestyle changes, emotional adjustment, health education, and tailored coaching, thus improving patients' overall quality of life across the disease course.
Objective
UNASSIGNED
The main objective of this study was to describe MS patients' self-reported experience of a nurse-led, telephone-based PSP and to explore its potential role in improving disease and therapy management skills.
Methods
UNASSIGNED
Survey data were analyzed from a subset of patients relapsing-remitting MS (RRMS) using interferon beta-1a already registered in the adveva
Results
UNASSIGNED
In total, 244 patient data at baseline were analyzed, of which 115 had a follow-up of at least 6 months. Results from this study provide an early view into the role of this PSP in improving the patients reported overall experience regarding disease management and injectable therapy, thus potentially ameliorating treatment adherence and decreasing health care cost. Moreover, study findings confirm the role of providing a patient-focused support by addressing non-medication-related topics in the PSP consultations. Indeed, patients involved in the adveva
Conclusions
UNASSIGNED
As such, it is reasonable to conclude that the involvement in the adveva
Identifiants
pubmed: 36092091
doi: 10.3389/fpsyg.2022.965229
pmc: PMC9454016
doi:
Types de publication
Journal Article
Langues
eng
Pagination
965229Informations de copyright
Copyright © 2022 Barello, Paolicelli, Bergamaschi, Cottone, D'Amico, Annibali, Paolillo, Bosio, Panetta and Graffigna.
Déclaration de conflit d'intérêts
Authors VA, AD'A, and AP contributed to this work as employees of Merck Serono S.p.A., Rome. VP contributed to this work as an employee of L'altrastatisticasrl, Consultancy & Training, Biostatistics Office, Rome. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Arch Phys Med Rehabil. 2021 Apr;102(4):694-701
pubmed: 33080210
J Crohns Colitis. 2010 Jun;4(2):171-5
pubmed: 21122501
Can Oncol Nurs J. 2008 Spring;18(2):64-73
pubmed: 18649698
Rheumatol Ther. 2017 Jun;4(1):85-96
pubmed: 28361468
J Adv Nurs. 2010 Aug;66(8):1780-92
pubmed: 20557392
J Nurs Adm. 2019 Nov;49(11):520-522
pubmed: 31651609
J Biomed Inform. 2016 Oct;63:150-156
pubmed: 27515924
Front Neurol. 2020 Aug 18;11:798
pubmed: 33013615
Patient Prefer Adherence. 2016 Apr 28;10:711-25
pubmed: 27175071
Medscape J Med. 2008;10(9):225
pubmed: 19008986
Expert Opin Drug Deliv. 2015;12(12):1829-35
pubmed: 26371561
Rural Remote Health. 2019 May;19(2):5270
pubmed: 31113205
Expert Opin Drug Deliv. 2016 Jun;13(6):799-805
pubmed: 26922837
Neurol Ther. 2021 Jun;10(1):75-98
pubmed: 33877583
Eur J Cardiovasc Nurs. 2010 Dec;9(4):203-17
pubmed: 20381427
PLoS One. 2019 Sep 19;14(9):e0222012
pubmed: 31536513
J Neurosci Nurs. 2013 Jun;45(3):E3-14
pubmed: 23636073
J Med Econ. 2013;16(2):213-20
pubmed: 23098539
J Hand Ther. 1997 Apr-Jun;10(2):183-91
pubmed: 9188037
J Pers Med. 2021 Jul 16;11(7):
pubmed: 34357139
Mult Scler. 2005 Apr;11(2):222-6
pubmed: 15795964
Eur J Neurol. 2006 Jul;13(7):700-22
pubmed: 16834700
Semin Oncol Nurs. 2016 May;32(2):134-43
pubmed: 27137470
Disabil Rehabil. 2019 Feb;41(3):250-264
pubmed: 28994622
J Telemed Telecare. 2020 Aug-Sep;26(7-8):400-413
pubmed: 31042118
Mult Scler. 2014 Nov;20(13):1795-8
pubmed: 24756569
BMC Neurol. 2020 Jul 14;20(1):281
pubmed: 32664928
Nurs Open. 2019 Jun 26;6(3):1189-1196
pubmed: 31367445
Am J Manag Care. 2010 Feb;16(2):139-44
pubmed: 20148619
Mult Scler Relat Disord. 2015 May;4(3):202-18
pubmed: 26008937
Nurs Econ. 2000 May-Jun;18(3):117-23
pubmed: 11052013
Oncol Nurs Forum. 2017 Jul 1;44(4):E168-E184
pubmed: 28632251
Adv Ther. 2020 Jun;37(6):2999-3009
pubmed: 32333326
J Psychosoc Nurs Ment Health Serv. 2017 Mar 1;55(3):31-37
pubmed: 28287673
Int J Environ Res Public Health. 2020 Jun 11;17(11):
pubmed: 32545278